Research programme: growth hormone releasing peptide analogues - Ardana

Drug Profile

Research programme: growth hormone releasing peptide analogues - Ardana

Alternative Names: EP 80317; Growth hormone releasing peptide analogues research programme - Ardana

Latest Information Update: 07 Feb 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ardana Bioscience
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cardiovascular disorders

Most Recent Events

  • 07 Feb 2005 Discontinued - Preclinical for Cardiovascular disorders in Canada (unspecified route)
  • 07 Feb 2005 Discontinued - Preclinical for Cardiovascular disorders in France (unspecified route)
  • 15 Sep 2004 Preclinical studies have been added to the Ischaemic Heart Disease pharmacodynamics section ,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top